Search research articles
Contact Us
Filters
Showing results (81-90 of 132) with videos related to
Page
of 14
Sort By:
Expert Review of Hematology
|
September 29, 2016
How to facilitate early diagnosis of CNS involvement in malignant lymphoma
Agnieszka Korfel, Martha Nowosielski, Javier Pardo-Moreno, et al.
Medicina (Kaunas, Lithuania)
|
September 28, 2021
Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study
Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
October 17, 2014
Myelomatous meningitis evaluated by multiparameter flow cytometry : report of a case and review of the literature
Alessandra Marini, Giovanni Carulli, Tiziana Lari, et al.
Leukemia Research
|
May 11, 2018
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation
Lorenzo Iovino, Francesco Mazziotta, Giovanni Carulli, et al.
Journal of Personalized Medicine
|
March 25, 2022
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network)
Vincenzo Sammartano, Elisabetta Antonioli, Gabriele Buda, et al.
Blood Reviews
|
June 30, 2026
MRD in multiple myeloma: Moving from "minimal" to "measurable"
Raffaella Cassano Cassano, Rahul Banerjee, Aimaz Afrough, et al.
Acta Haematologica
|
November 8, 2016
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up
Alessia Bari, Raffaella Marcheselli, Luigi Marcheselli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 10, 2010
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)
Nicola Di Renzo, Antonella Montanini, Donato Mannina, et al.
European Heart Journal. Cardiovascular Imaging
|
December 23, 2024
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis
Giuseppe Vergaro, Alberto Aimo, Dario Genovesi, et al.
Frontiers in Oncology
|
May 14, 2023
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network
Elisabetta Antonioli, Sofia Pilerci, Irene Attucci, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 132) with videos related to
Sort By:
Page
of 14
Expert Review of Hematology
|
September 29, 2016
How to facilitate early diagnosis of CNS involvement in malignant lymphoma
Agnieszka Korfel, Martha Nowosielski, Javier Pardo-Moreno, et al.
Medicina (Kaunas, Lithuania)
|
September 28, 2021
Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study
Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
October 17, 2014
Myelomatous meningitis evaluated by multiparameter flow cytometry : report of a case and review of the literature
Alessandra Marini, Giovanni Carulli, Tiziana Lari, et al.
Leukemia Research
|
May 11, 2018
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation
Lorenzo Iovino, Francesco Mazziotta, Giovanni Carulli, et al.
Journal of Personalized Medicine
|
March 25, 2022
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network)
Vincenzo Sammartano, Elisabetta Antonioli, Gabriele Buda, et al.
Blood Reviews
|
June 30, 2026
MRD in multiple myeloma: Moving from "minimal" to "measurable"
Raffaella Cassano Cassano, Rahul Banerjee, Aimaz Afrough, et al.
Acta Haematologica
|
November 8, 2016
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up
Alessia Bari, Raffaella Marcheselli, Luigi Marcheselli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 10, 2010
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)
Nicola Di Renzo, Antonella Montanini, Donato Mannina, et al.
European Heart Journal. Cardiovascular Imaging
|
December 23, 2024
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis
Giuseppe Vergaro, Alberto Aimo, Dario Genovesi, et al.
Frontiers in Oncology
|
May 14, 2023
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network
Elisabetta Antonioli, Sofia Pilerci, Irene Attucci, et al.
Page
of 14